The activation of TIMP2 in tumor cells inhibits tumor cell growth in vivo and suppresses epithelial-to-mesenchymal transition (EMT), which is associated with tumor characteristics of aggressiveness and metastatic potential [35]. The gene discussed is TIMP2; the disease is neoplasm.